Smith, Moore & Co’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,613
Closed -$229K 482
2024
Q3
$229K Buy
+3,613
New +$261K 0.02% 417
2024
Q2
Sell
-2,832
Closed -$224K 443
2024
Q1
$224K Hold
2,832
0.02% 390
2023
Q4
$220K Buy
+2,832
New +$210K 0.03% 378

Other funds holding ACHC

Smith, Moore & Co's ACHC Position: Q4 2024 in Review

Smith, Moore & Co sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 3,613 shares — an estimated $229K sold.

Smith, Moore & Co first reported a position in ACHC in Q4 2023 and held it in 3 quarters. The position peaked at $229K in Q3 2024. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Smith, Moore & Co reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Smith, Moore & Co sold 3,613 Acadia Healthcare shares in Q4 2024, an estimated $229K.
  • Smith, Moore & Co first reported a position in Acadia Healthcare in Q4 2023 and held it in 3 quarters.
  • Smith, Moore & Co's Acadia Healthcare position peaked at $229K in Q3 2024.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Smith, Moore & Co's 13F filing for Q4 2024, filed 13 Feb 2025.